Literature DB >> 32049741

What are the epileptic encephalopathies?

Marina Trivisano1, Nicola Specchio.   

Abstract

PURPOSE OF REVIEW: To review the evolution of the concept of epileptic encephalopathy during the course of past years and analyze how the current definition might impact on both clinical practice and research. RECENT
FINDINGS: Developmental delay in children with epilepsy could be the expression of the cause, consequence of intense epileptiform activity (seizures and EEG abnormalities), or because of the combination of both factors. Therefore, the current International League Against Epilepsy classification identified three electroclinical entities that are those of developmental encephalopathy, epileptic encephalopathy, and developmental and epileptic encephalopathy (DEE). Many biological pathways could be involved in the pathogenesis of DEEs. DNA repair, transcriptional regulation, axon myelination, metabolite and ion transport, and peroxisomal function could all be involved in DEE. Also, epilepsy and epileptiform discharges might impact on cognition via several mechanisms, although they are not fully understood.
SUMMARY: The correct and early identification of cause in DEE might increase the chances of a targeted treatment regimen. Interfering with neurobiological processes of the disease will be the most successful way in order to improve both the cognitive disturbances and epilepsy that are the key features of DEE.

Entities:  

Mesh:

Year:  2020        PMID: 32049741     DOI: 10.1097/WCO.0000000000000793

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  6 in total

1.  Defining the phenotype of FHF1 developmental and epileptic encephalopathy.

Authors:  Marina Trivisano; Alessandro Ferretti; Elizabeth Bebin; Linda Huh; Gaetan Lesca; Aleksandra Siekierska; Ryo Takeguchi; Maryline Carneiro; Luca De Palma; Ilaria Guella; Kazuhiro Haginoya; Ruo Ming Shi; Atsuo Kikuchi; Tomoko Kobayashi; Julien Jung; Lieven Lagae; Mathieu Milh; Marie L Mathieu; Berge A Minassian; Antonio Novelli; Nicola Pietrafusa; Eri Takeshita; Marco Tartaglia; Alessandra Terracciano; Michelle L Thompson; Gregory M Cooper; Federico Vigevano; Laurent Villard; Nathalie Villeneuve; Gunnar M Buyse; Michelle Demos; Ingrid E Scheffer; Nicola Specchio
Journal:  Epilepsia       Date:  2020-07-09       Impact factor: 5.864

2.  Lanthanum Chloride Induces Axon Abnormality Through LKB1-MARK2 and LKB1-STK25-GM130 Signaling Pathways.

Authors:  Zeli Song; Haoyue Mao; Jinxuan Liu; Wenchang Sun; Shengwen Wu; Xiaobo Lu; Cuihong Jin; Jinghua Yang
Journal:  Cell Mol Neurobiol       Date:  2022-06-05       Impact factor: 5.046

3.  Clinical whole exome sequencing revealed de novo heterozygous stop-gain and missense variants in the STXBP1 gene associated with epilepsy in Saudi families.

Authors:  Muhammad Imran Naseer; Angham Abdulrhman Abdulkareem; Mahmood Rasool; Bader Shirah; Hussein Algahtani; Osama Y Muthaffar; Peter Natesan Pushparaj
Journal:  Saudi J Biol Sci       Date:  2022-05-20       Impact factor: 4.052

4.  Home-cage behavior in the Stargazer mutant mouse.

Authors:  Catharina Schirmer; Mark A Abboud; Samuel C Lee; John S Bass; Arindam G Mazumder; Jessica L Kamen; Vaishnav Krishnan
Journal:  Sci Rep       Date:  2022-07-27       Impact factor: 4.996

5.  Development and validation of a nomogram for the early prediction of drug resistance in children with epilepsy.

Authors:  Hua Geng; Xuqin Chen
Journal:  Front Pediatr       Date:  2022-08-30       Impact factor: 3.569

Review 6.  Concise Review: Stem Cell Models of SCN1A-Related Encephalopathies-Current Perspective and Future Therapies.

Authors:  Valery Zayat; Roza Szlendak; Dorota Hoffman-Zacharska
Journal:  Cells       Date:  2022-10-04       Impact factor: 7.666

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.